Article Details

Benefits Observed With Second Dose of Eptinezumab in Chronic, Episodic Migraine

Retrieved on: 2022-06-11 20:18:16

Tags for this article:

Click the tags to see associated articles and topics

Benefits Observed With Second Dose of Eptinezumab in Chronic, Episodic Migraine. View article details on hiswai:

Excerpt

Eptinezumab, a humanized monoclonal antibody that binds to calcitonin gene-related peptide ligand and blocks its binding to the receptor, ...

Article found on: www.neurologylive.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up